UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
For the month of September, 2023.
Commission File Number 001-40736
(Translation of registrant’s name into English)
Claude Dornier Straße 1
Bldg. 335, 82234
Wessling, Germany
Telephone: +49 160 9704 6857
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
CONTENTS
Explanatory Note
On September 15, 2023, Lilium N.V. (the “Company”) issued (i) its Unaudited Condensed Interim Financial Statements as of and for the six months ended June 30, 2023 and (ii) its Management’s Discussion & Analysis of Financial Condition and Results of Operations for the six months ended June 30, 2023, which are furnished as Exhibits 99.1 and 99.2 to this Report on Form 6-K, respectively.
Incorporation by Reference
The contents of this Report on Form 6-K, including Exhibits 99.1 and 99.2, are hereby incorporated by reference into the Company’s registration statements on Form F-3 filed with the U.S. Securities and Exchange Commission (“SEC”) on June 9, 2023 (File No. 333-272571), February 3, 2023 (File No. 333-269568), November 25, 2022, as amended or supplemented (File No. 333-268562), and October 3, 2022, as amended or supplemented (File Nos. 333-267718 and 333-267719), and the Company’s registration statement on Form S-8 filed with the SEC on November 18, 2021 (File No. 333-261175).
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Dated: September 15, 2023 | Lilium N.V. | |
| ||
| By: | /s/ Klaus Roewe |
| Name: Klaus Roewe | |
| Title: Chief Executive Officer and Executive Director |
Exhibit 99.1
Interim Condensed Consolidated Statements of Operations and Other Comprehensive Income (Loss) for the six month periods ended June 30, 2023 and 2022
in € thousand |
| Note |
| June 30, 2023 |
| June 30, 2022 |
Research and development expenses |
| [5] |
| ( |
| ( |
General and administrative expenses |
| [6] |
| ( |
| ( |
Selling expenses |
| [7] |
| ( |
| ( |
Other income |
| |
| | ||
Other expenses |
| ( |
| ( | ||
Operating loss |
| ( |
| ( | ||
Finance income |
| [8] |
| |
| |
Finance expenses |
| [8] |
| ( |
| ( |
Financial result |
| [8] |
| ( |
| |
Share of loss in a joint venture |
| [11] |
| ( |
| ( |
Loss before income tax |
| ( |
| ( | ||
Income tax (expense) / benefits |
| [9] |
| ( |
| |
Net loss for the period |
| ( |
| ( |
Other comprehensive income / (loss)
in € thousand (except per share data) |
| Note |
| June 30, 2023 |
| June 30, 2022 |
Other comprehensive income / (loss) that may be reclassified to profit or loss |
| |
| ( | ||
Exchange differences on translation of foreign business units |
| |
| ( | ||
Items that will not be subsequently reclassified to profit or loss |
| |
| ( | ||
Remeasurement of defined pension benefit obligation |
| |
| ( | ||
Other comprehensive income / (loss) |
| |
| ( | ||
Total consolidated comprehensive loss for the period |
| ( |
| ( | ||
Loss per share (basic and diluted) in € |
| ( |
| ( |
The accompanying notes are an integral part of these interim condensed consolidated financial statements (IFRS).
1
Interim Condensed Consolidated Statement of Financial Position as of June 30, 2023 and December 31, 2022
in € thousand |
| Note |
| 06/30/2023 |
| 12/31/2022 |
ASSETS | ||||||
Intangible assets |
| |
| | ||
Property, plant and equipment |
| [10] | |
| | |
Investment in a joint venture |
| [11] | |
| | |
Other financial assets | [12] | |
| | ||
Non-financial assets |
| [13] | |
| | |
Non-current assets | |
| | |||
Other financial assets |
| [12] | |
| | |
Non-financial assets |
| [13] | |
| | |
Income tax receivable | | | ||||
Cash and cash equivalents | |
| | |||
Current assets | |
| | |||
Total Assets | |
| | |||
SHAREHOLDERS’ (DEFICIT) / EQUITY AND LIABILITIES | ||||||
Subscribed capital |
| [14] | |
| | |
Share premium | [14] | |
| | ||
Other capital reserves |
| [14] | |
| | |
Treasury shares | [14] | ( |
| ( | ||
Accumulated loss | ( |
| ( | |||
Accumulated other comprehensive income | |
| | |||
Shareholders’ (deficit) / equity | ( |
| | |||
Other financial liabilities |
| [16] | |
| | |
Lease liabilities | |
| | |||
Provisions |
| |
| | ||
Trade and other payables | |
| | |||
Deferred tax liabilities | — |
| | |||
Non-current liabilities | |
| | |||
Other financial liabilities |
| [16] | |
| | |
Lease liabilities | |
| | |||
Share-based payment liability | [15] | |
| | ||
Provisions | |
| | |||
Income tax payable | |
| | |||
Warrants |
| [17] | |
| | |
Trade and other payables | |
| | |||
Other non-financial liabilities | |
| | |||
Current liabilities | |
| | |||
Total Shareholders’ (Deficit) / Equity and Liabilities | |
| |
The accompanying notes are an integral part of these interim condensed consolidated financial statements (IFRS).
2
Interim Condensed Consolidated Statement of Changes in Shareholders’ Equity for the six month periods ended June 30, 2023 and 2022
|
|
|
|
|
|
| Accumulated other |
| ||||||||||
comprehensive income | ||||||||||||||||||
| Remeasurement | |||||||||||||||||
of defined | ||||||||||||||||||
Other | Currency | pension | ||||||||||||||||
Subscribed | Share | capital | Treasury | Accumulated | translation | benefit | ||||||||||||
in € thousand | Note |
| capital |
| premium |
| reserves |
| shares |
| loss |
| reserve |
| obligation |
| Total | |
January 1, 2022 | | | | ( | ( | | | | ||||||||||
Loss for the period | — | — | — | — | ( | — |
| — | ( | |||||||||
Other comprehensive loss | — | — | — | — | — | ( |
| ( | ( | |||||||||
Total comprehensive loss | — | — | — | — | ( | ( |
| ( | ( | |||||||||
Share-based payment awards | [15] | — | — | | — | — | — |
| — | | ||||||||
Conversion share-based payment awards into shares | [15] | | | ( | — | — | — |
| — | | ||||||||
Share capital increase - ELOC | [14] | | — | | — | — | — | — | | |||||||||
June 30, 2022 | | | | ( | ( | |
| ( | | |||||||||
January 1, 2023 | | | | ( | ( | |
| | | |||||||||
Loss for the period | — | — | — | — | ( | — |
| — | ( | |||||||||
Other comprehensive income | — | — | — | — | — | |
| | | |||||||||
Total comprehensive (loss)/income | — | — | — | — | ( | |
| | ( | |||||||||
Share-based payment awards | [15] | — | — | | — | — | — |
| — | | ||||||||
Conversion share-based payment awards into shares | [15] | | — | ( | — | — | — |
| — | | ||||||||
Conversion of Class B shares | [14] | — | | — | ( | — | — | — | — | |||||||||
Cancellation of issued shares | [14] | ( | — | — | | — | — | — | — | |||||||||
Contribution from shareholder | [17] | — | — | | — | — | — | — | | |||||||||
June 30, 2023 | | | | ( | ( | |
| | ( |
The accompanying notes are an integral part of these interim condensed consolidated financial statements (IFRS).
3
Interim Condensed Consolidated Statement of Cash Flows for the six month periods ended June 30, 2023 and 2022
in € thousand |
| June 30, 2023 |
| June 30, 2022 |
Net loss for the period |
| ( |
| ( |
Adjustments to reconcile consolidated net loss to net cash flows: |
|
| ||
Income tax expense/(benefits) |
| |
| ( |
Net interest |
| ( |
| |
Depreciation, amortization and impairment |
| |
| |
Expenses for share-based payments |
| |
| |
Share of loss in a joint venture |
| |
| |
Fair value changes of financial instruments and expected credit losses (ECL) |
| |
| ( |
Income taxes paid |
| |
| ( |
Change in provisions |
| ( |
| |
Working capital adjustments: |
|
| ||
Changes in trade and other payables |
| |
| |
Changes in other assets and liabilities |
| |
| ( |
Cash flow from operating activities |
| ( |
| ( |
Purchases of intangible assets |
| ( |
| ( |
Purchases of and advance payments on property, plant and equipment |
| ( |
| ( |
Disposals of intangible assets, property, plant and equipment |
| — |
| |
Proceeds from short-term investments |
| |
| |
Payments for short-term investments |
| ( |
| ( |
Interest paid |
| — |
| ( |
Interest received |
| |
| — |
Cash flow from investing activities |
| ( |
| |
Proceeds from issue of May 2023 Warrants |
| |
| — |
Proceeds from share capital increase and capital contribution |
| |
| |
Principal elements of lease payments |
| ( |
| ( |
Interest paid |
| ( |
| ( |
Cash flow from financing activities |
| |
| ( |
Cash-based changes in cash and cash equivalents |
| ( |
| ( |
Effect of foreign exchange rate changes on cash and cash equivalents |
| ( |
| |
Effect of change in expected credit loss provisions | | — | ||
Net decrease in cash and cash equivalents |
| ( |
| ( |
Cash and cash equivalents at the beginning of the period |
| |
| |
Cash and cash equivalents at the end of the period |
| |
| |
The accompanying notes are an integral part of these interim condensed consolidated financial statements (IFRS).
4
Table of Contents
6 | |||
Basis of Preparation and Changes to the Group’s Accounting Policies | 6 | ||
8 | |||
Covid-19 Risks and Uncertainties, War in Ukraine and Geopolitical Conflicts | 8 | ||
8 | |||
9 | |||
9 | |||
9 | |||
9 | |||
10 | |||
10 | |||
10 | |||
11 | |||
11 | |||
13 | |||
19 | |||
19 | |||
21 | |||
24 | |||
24 | |||
26 |
5
1.Corporate Information
Lilium N.V. (“the Company”), together with its consolidated entities (“Lilium” or the “Group”), is a technology company in the field of urban air mobility and intends to make regional air mobility a reality. Since its founding, Lilium has primarily engaged in research and development of a proprietary electric Vertical Takeoff and Landing (eVTOL) jet (the “Lilium Jet”) for production and operation of a regional air mobility service as well as related services.
Lilium N.V. is a public company under Dutch law and is registered under the Dutch trade register number 82165874. Lilium N.V. has its activities exclusively in Germany. The registered headquarters is Claude-Dornier Str. 1, Geb. 335, 82234 Wessling, Germany. The Company is publicly listed and traded on Nasdaq under the symbols “LILM” for its Class A ordinary shares (“Class A shares”) and “LILMW” for its listed redeemable warrants (“Public Warrants”) since September 15, 2021.
The interim condensed consolidated financial statements of the Group, for the six month period ended June 30, 2023, were authorized for issue by the Company’s Board of Directors (“the Board”) on September 13, 2023.
2.Basis of Preparation and Changes to the Group’s Accounting Policies
The Group’s interim condensed consolidated financial statements for the six month periods ended June 30, 2023 and 2022 are prepared in accordance with IAS 34 Interim Financial Reporting.
The interim condensed consolidated financial statements have been prepared on a going concern basis, applying a historical cost convention, unless otherwise indicated. They are prepared and reported in thousands of Euro (“€ thousand”) except where otherwise stated. Due to rounding, numbers presented may not add up precisely to the totals provided and percentages may not precisely reflect the absolute figures.
The interim condensed consolidated financial statements do not include all the information and disclosures required in the annual financial statements and should be read in conjunction with the Group’s audited annual consolidated financial statements as of December 31, 2022.
Consolidated entities are as follows:
|
|
| equity interest |
| |||||
owned in % | |||||||||
Country of | Date of | June 30, | June 30, |
| |||||
Name | Incorporation | incorporation | 2022 | 2023 | |||||
Lilium N.V. |
| Netherlands | March 11, 2021 |
| n/a | n/a | |||
Lilium GmbH |
| Germany | February 11, 2015 |
| | % | | % | |
Lilium Schweiz GmbH |
| Switzerland | December 8, 2017 |
| | % | | % | |
Lilium Aviation UK Ltd. |
| United Kingdom | December 20, 2017 |
| | % | | % | |
Lilium Aviation Inc. |
| United States | July 1, 2020 |
| | % | | % | |
Lilium eAircraft GmbH |
| Germany | August 17, 2020 |
| | % | | % | |
Stichting JSOP |
| Netherlands | September 10, 2021 |
| | % | | % | |
Lilium Aviation Spain SLU |
| Spain | April 7, 2022 |
| | % | | % |
Going Concern
The financial statements have been prepared on a basis that assumes the Group will continue as a going concern and which contemplates the realization of assets and satisfaction of liabilities and commitments in the ordinary course of business. Management assessed the Group’s ability to continue as a going concern and evaluated whether there are certain conditions and events, considered in the aggregate, that raise substantial doubt about the Group’s ability to continue as a going concern using all information available about the future, focusing on the twelve-month period after the issuance date of the financial statements.
6
Historically, the Group has funded its operations primarily through capital raises and loans from shareholders. Since its inception, the Group has incurred recurring losses and negative cash flows from operations (accumulated losses of €
Lilium’s financing plan shows substantial financing needs for several years. Based on its business plan, the Group depends on additional financing for development activities and operations which is currently not assured.
The Group’s current forecast indicates that the Group does not have sufficient funds to fund its operations for several years. Additionally, the Group must reach several milestones, including completion of its research and development program, and obtaining regulatory approvals, which will have an increased importance as the Group progresses towards commercialization. Consequently, the Group’s ability to continue as a going concern is largely dependent on its ability to successfully progress with its business model and to secure additional funds in the near future through a combination of debt financings, equity offerings, partnerships and grant funding. The Group plans to secure additional capital in the next 12 months and beyond through, for example, equity offerings, grants, debt financing, or collection of pre-delivery payments (“PDPs”) in order to continue as a going concern. Between the reporting date and the date these financial statements were made available, the Group received additional gross funding of approximately US$
There is no certainty that the Group will be successful in obtaining sufficient funding through PDPs, grants, additional private or public offerings of debt and/or equity. If the Group is unsuccessful in raising sufficient capital, the Group’s management will be required to undertake, and is committed to undertaking, additional significant cost-cutting measures including significant headcount reductions that could require us to curtail or discontinue our operations. Such cost-cutting measures should help maintain the liquidity of the Group within the twelve-month period from the issuance date of these interim consolidated financial statements and provide additional time for raising sufficient funds through the start of series production.
Based on its recurring losses from operations since inception, expectation of continuing operating losses in the future and the need to raise additional capital to finance its future operations, which is not assured yet, the Group has concluded that there is substantial doubt about its ability to continue as a going concern, and, therefore, that it may be unable to realize its assets and discharge its liabilities in the normal course of business. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. Despite this substantial doubt, management is continuing to take actions to secure sufficient financing, and thus believes that the application of the going concern assumption for the preparation of these consolidated financial statements is appropriate.
New standards, interpretations and amendments adopted by the Group
The accounting policies adopted in the preparation of the interim condensed consolidated financial statements are consistent with those followed in the preparation of the Group’s audited annual consolidated financial statements for the year ended December 31, 2022, except for the adoption of new standards effective as of January 1, 2023. The Group has not early adopted any standard, interpretation or amendment that has been issued but is not yet effective.
Several amendments apply for the first time in 2023, but do not have an impact on the interim condensed consolidated financial statements of the Group.
7
3.Significant Accounting Judgments, Estimates and Assumptions
The preparation of the Group’s interim condensed consolidated financial statements requires management to make judgements, estimates and assumptions that affect the reported amounts in the interim condensed consolidated financial statements. In preparing these interim condensed consolidated financial statements, management exercises its best judgement based upon its experience and the circumstances prevailing at that time. The estimates and assumptions are based on available information and conditions at the end of the financial period presented and are reviewed on an ongoing basis. Actual results may differ from these estimates under different assumptions and conditions and may materially affect the financial results or the financial position reported in future periods.
Assumptions and estimates relating to the Group’s ability to continue as a going concern are described in note 2.
The Group operates its business as a single operating segment, which is also its reporting segment. An operating segment is defined as a component of an entity for which discrete financial information is available and whose results of operations are regularly reviewed by the chief operating decision maker. The Group’s chief operating decision maker is the Chief Executive Officer, who reviews results of operations to make decisions about allocating resources and assessing performance based on consolidated financial information.
4.Covid-19 Risks and Uncertainties, War in Ukraine and Geopolitical Conflicts
The Board is actively monitoring the impact on the Group from the uncertainty regarding the consequences and lingering impact of the COVID-19 pandemic. The Group had implemented logistical and organizational changes to bolster the Group’s resilience to the COVID-19 pandemic. The extent that COVID-19 continues to impact our business, prospects and results of operations will depend on future developments, which are highly uncertain and cannot be predicted. However, based on the latest developments, the Group expects business operations to continue with minimal to no ongoing impact from the COVID-19 pandemic for the foreseeable future.
The Board is also actively monitoring the impact on the Group from the war in Ukraine. The Group does not and does not intend to have any operations in Ukraine, Belarus or Russia, or engage with direct suppliers located in Ukraine, Belarus or Russia. There is currently no direct impact on the Group from the war in Ukraine and sanctions imposed on Russia and Belarus as the Group does not have any operations or direct suppliers located in these jurisdictions. The Group continues to closely monitor the impact on general economic factors from the war in Ukraine, including the impact of inflation, as such puts pressure on the Group’s costs for employees, raw materials and other parts provided by suppliers.
Finally, the Board is also actively monitoring geopolitical conflicts and tension, including the imposition of and changes in foreign investment, economic sanctions and trade control regulations that could adversely impact our business. There is currently no material impact on the Group’s operations from applicable foreign investment, economic sanctions and trade control regulations. However, the imposition of and changes in such regulations in the future could adversely impact our business.
5.Research and Development Expenses
For the six month period ended June 30, 2023, research and development expenses consisted of €
8
6.General and Administrative Expenses
For the six month period ended June 30, 2023, general and administrative expenses included €
7.Selling Expenses
For the six month period ended June 30, 2023, selling expenses consisted of €
8.Financial Result
Financial result is comprised of the following for the six month periods ended June 30, 2023 and 2022:
In € thousand |
| June 30, 2023 |
| June 30, 2022 |
Finance income | | | ||
thereof: fair value changes |
| — |
| |
thereof: foreign currency exchange gains / (losses) on financial instruments | | ( | ||
thereof: reversal of expected credit losses |
| — |
| |
thereof: other interest income | | — | ||
Finance expenses |
| ( |
| ( |
thereof: fair value changes |
| ( |
| ( |
thereof: interest portion of lease payments |
| ( |
| ( |
thereof: expected credit losses |
| ( |
| ( |
thereof: other interest expenses |
| ( |
| — |
Financial result |
| ( |
| |
Finance income in the current period resulted from foreign currency gain on warrant liabilities of €
Finance expenses in the current period mainly resulted from the fair value changes of the warrant revaluation of €
9.Income Taxes
The Group calculated the period income tax expense, during the six month period ended June 30, 2023 for which the Group recorded consolidated income tax expense of €
Major deferred income taxes have not been recorded. The netting of deferred tax liabilities and deferred tax assets results in a net deferred tax asset. The net deferred tax asset has been valued at zero. Deferred tax assets on the tax losses carried forward are not recognized either given the tax losses carried forward relate to entities with a history of losses.
9
10.Property, Plant and Equipment
During the six month period ended June 30, 2023, the Group acquired assets with a cost of €
In € thousand |
| June 30, 2023 |
| December 31, 2022 |
Right to land and buildings and leasehold improvements | | | ||
Vehicles | | | ||
Technical equipment and machinery |
| |
| |
Office and other equipment |
| |
| |
Assets under construction |
| |
| |
Carrying amount |
| |
| |
No indicators of impairment were identified which would have required items of property, plant and equipment to be tested for impairment in the six month periods ended June 30, 2023 and 2022.
11.Investment in a Joint Venture
Investment in Ionblox
The movement in the investment in Ionblox, Inc (“Ionblox”) during the period was as follows:
In € thousand |
| Carrying Value |
January 1, 2023 | | |
Share of loss in a joint venture |
| ( |
June 30, 2023 |
| |
12.Other Financial Assets
Other financial assets are as follows:
In € thousand |
| June 30, 2023 |
| December 31, 2022 |
Security deposits |
| |
| |
Total non-current financial assets |
| |
| |
Fixed term deposits |
| |
| |
Security deposits |
| |
| |
Total current other financial assets |
| |
| |
Lilium has placed part of its liquidity in fixed term deposits with a remaining term of more than
10
13.Non-Financial Assets
Non-financial assets are as follows:
In € thousand |
| June 30, 2023 |
| December 31, 2022 |
Advance payments | | | ||
Prepaid expenses | | | ||
Total non-current non-financial assets |
| |
| |
Value added tax claims |
| |
| |
Prepaid expenses |
| |
| |
Miscellaneous other current non-financial assets |
| |
| |
Total current non-financial assets |
| |
| |
Total non-financial assets |
| |
| |
14.Shareholders’ (deficit) / equity
The movements of the shares issued during the six month periods ended June 30, 2023 and 2022, are as follows:
Common | Supervoting | Ordinary | ||||||
shares | shares | shares | ||||||
(in units) |
| (Class A) |
| (Class B) |
| (Class C) |
| Total |
Issued at January 1, 2023 |
| |
| |
| |
| |
Issued shares for share-based payments exercised |
| |
| — |
| — |
| |
Conversion of Class B Shares | | ( | | | ||||
Cancellation of issued shares |
| — |
| ( |
| ( |
| ( |
Issued as of June 30, 2023 | | | | | ||||
Treasury shares | — | — | ( | ( | ||||
Outstanding as of June 30, 2023 |
| |
| |
| — |
| |
Common | Supervoting | Ordinary | ||||||
shares | shares | shares | ||||||
(in units) |
| (Class A) |
| (Class B) |
| (Class C) |
| Total |
Issued at January 1, 2022 |
| |
| |
| — |
| |
Issued shares for share-based payments exercised |
| |
| — |
| — |
| |
Warrants exercised |
| |
| — |
| — |
| |
ELOC commitment shares |
| |
| — |
| — |
| |
Issued as of June 30, 2022 |
| |
| |
| — |
| |
Treasury shares | ( | — | — | ( | ||||
Treasury shares (due to consolidation) | ( | — | — | ( | ||||
Outstanding as of June 30, 2022 |
| |
| |
| — |
| |
During the six month period ended June 30, 2023, in total
During the six month period ended June 30, 2023, €
11
Cancellation of issued shares
During the period the Group cancelled
Conversion of Class B Shares
During February 2023, a shareholder who is an executive director and a member of key management personnel of Lilium N.V. converted
Treasury shares
The reserve for treasury shares represents the nominal amount of Lilium N.V.’s own shares held in treasury. Payments for treasury shares above or below nominal value are deducted from or added to share premium, respectively. The movement of treasury shares during periods are as follows:
| Common |
| Supervoting |
| Ordinary |
| ||
shares | shares | shares | ||||||
(in units) | (Class A) | (Class B) | (Class C) | Total | ||||
At January 1, 2023 |
| — |
| |
| |
| |
Conversion of Class B shares |
| — |
| — |
| |
| |
Cancellation of Class B shares |
| — |
| ( |
| ( |
| ( |
At June 30, 2023 |
| — |
| — |
| |
| |
| Common |
| Supervoting |
| Ordinary |
| ||
shares | shares | shares | ||||||
(in units) | (Class A) | (Class B) | (Class C) | Total | ||||
At January 1, 2022 and June 30, 2022 |
| |
| — |
| — |
| |
12
15.Share-based Payments
Overview
Lilium offers several share-based plans as summarized in the table below.
The table below summarizes the expense/(income) recorded for share-based payments in the six month periods ended June 30, 2023 and 2022:
In € thousand |
| June 30, 2023 |
| June 30, 2022 |
Equity-settled | ||||
General population and executives – standard ESOP |
| |
| |
General population – Restricted Stock Units (“RSU”) |
| |
| |
Executives – ESOP modified |
| |
| |
Executives – RSU |
| |
| |
Executives – Performance-based stock options |
| |
| ( |
Executives – Time-based stock options |
| |
| |
Share-based payment – Vendor | | — | ||
Cash-settled | ||||
Joint stock ownership Plan (JSOP) incl. bonus |
| — |
| ( |
Executives – Success fees | — | | ||
Total expense |
| |
| |
General population and Executives - standard Employee Stock Option Program (“ESOP”)
The expense recognized for participant services received during the six month periods ended June 30, 2023 and 2022 is shown in the following table:
In € thousand |
| June 30, 2023 |
| June 30, 2022 |
Expense arising from equity-settled share-based payments |
| |
| |
There were
Movements during the period
The following table illustrates the number and WAEP of, and movements in, such Lilium N.V. share options during the six month periods ended June 30, 2023 and 2022:
Equity-settled options:
2023 | 2022 | |||||||||
Number | 2023 | Number | 2022 | |||||||
(in units) |
| of options |
| WAEP |
| of options |
| WAEP | ||
Outstanding at January 1 |
| | € |
| | € | ||||
Granted during the period |
| — | € |
| | € | ||||
Forfeited during the period |
| ( | € |
| ( | € | ||||
Exercised during the period |
| ( | € |
| ( | € | ||||
Transferred to cash-settled |
| — | € |
| ( | € | ||||
Outstanding at June 30 |
| | € |
| | € |
13
Cash-settled options: |
| 2023 |
| 2023 |
| 2022 |
| 2022 | ||
(in units) | Number of options | WAEP | Number of options | WAEP | ||||||
Outstanding at January 1 and June 30 |
| | € | |
| | € | |
The weighted average remaining contractual life is
Total options that vested during the period were
As of June 30, 2023,
General population - Restricted Stock Units
The expense recognized for participant services received during the six month periods ended June 30, 2023 and 2022 is shown in the following table:
In € thousand |
| June 30, 2023 |
| June 30, 2022 |
Expense arising from equity settled RSU |
| |
| |
Movements during the periods
The following table illustrates the number and WAEP of, and movements in, such RSUs during the six month periods ended June 30, 2023 and 2022:
2023 | 2022 | |||||||||
Number | 2023 | Number | 2022 | |||||||
(in units) |
| of RSUs |
| WAEP |
| of RSUs |
| WAEP | ||
Outstanding at January 1 |
| | € | |
| |
| € | | |
Assigned during the period |
| | € | |
| |
| € | | |
Exercised during the period | ( | € | | — | — | |||||
Forfeited during the period |